Triochem Products Share Price | Triochem Products Stock Screener
TRIPR
Pharmaceuticals
Track Triochem Products share price live with TickJournal's free stock screener.
Analyse TRIPR price movement history and track historical price performance.
Use the Triochem Products stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Triochem Products Market Cap
₹0.40 Cr.
TRIPR P/E Ratio (TTM)
15.00
Triochem Products P/B Ratio
0.04
EPS (TTM)
₹325.34
Dividend Yield
-
Debt to Equity
-
TRIPR 52 Week High
-
Triochem Products 52 Week Low
-
Operating Margin
-
Profit Margin
-
TRIPR Revenue (TTM)
-
EBITDA
₹-1.00
Net Income
₹8.00
Total Assets
₹21.00
Total Equity
₹21.00
Triochem Products Share Price Chart
Screen Triochem Products share price with an interactive chart. Analyse TRIPR price trends and volatility across different timeframes.
Triochem Products Company Profile - Fundamental Screener
Screen Triochem Products company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for TRIPR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE331E01013
Triochem Products Balance Sheet Screener
Screen TRIPR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 21 | 14 | 15 | 12 | 13 | 12 | 17 | 15 | 12 | 10 |
| Current Assets | 13 | 3 | 3 | 1 | 12 | 11 | 15 | 14 | 10 | 8 |
| Fixed Assets | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 21 | 14 | 15 | 12 | 13 | 12 | 12 | 9 | 8 | 6 |
| Share Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves & Surplus | 20 | 13 | 14 | 11 | 13 | 12 | 12 | 9 | 8 | 5 |
Triochem Products Income Statement Screener - Profit & Revenue Analysis
Screen Triochem Products income statement and profit fundamentals.
Analyze TRIPR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Triochem Products share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 1 | 0 | 9 | 14 | 21 | 12 | 35 | 18 | 23 | 31 |
| Expenses | 1 | 1 | 1 | 1 | 8 | 14 | 16 | 11 | 31 | 17 | 22 | 30 |
| EBITDA | -1 | 0 | 0 | -1 | 2 | 0 | 5 | 2 | 4 | 1 | 1 | 1 |
| Operating Profit % | 0.00% | 0.00% | 0.00% | 0.00% | 15.00% | -3.00% | 22.00% | 13.00% | 11.00% | 5.00% | 4.00% | 4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 11 | 0 | -1 | -1 | 2 | -1 | 5 | 1 | 4 | 1 | 1 | 1 |
| Tax | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
| Net Profit | 8 | 0 | -1 | -1 | 1 | 0 | 3 | 1 | 3 | 1 | 0 | 0 |
| EPS | 325.34 | -16.33 | -41.36 | -36.12 | 53.99 | -18.24 | 138.89 | 30.33 | 104.29 | 23.51 | 13.94 | 16.98 |
Triochem Products Cash Flow Screener - Liquidity Fundamentals
Screen TRIPR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | -4 | -1 | 4 | 10 | 4 | -4 | 2 | -7 | 7 |
| Investing Activities | 0 | 3 | -10 | 0 | 0 | 0 | 0 | 0 | 4 | -4 |
| Financing Activities | 0 | 0 | 0 | 0 | -3 | -4 | 3 | -1 | 3 | -4 |
| Net Cash Flow | 0 | 0 | -11 | 4 | 8 | 0 | -1 | 1 | 0 | -1 |
Triochem Products Shareholding Pattern Screener
See Triochem Products shareholding pattern with promoter, FII, and DII holdings.
Check Triochem Products promoter holding and ownership changes for TRIPR on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 68.65% | 68.65% | 68.65% | 68.65% | 68.65% | 68.65% | 68.65% | 68.65% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.53% | 15.53% | 15.53% | 15.53% | 15.53% | 15.53% | 15.53% | 15.53% |
| Other Holding | 15.82% | 15.82% | 15.82% | 15.82% | 15.82% | 15.82% | 15.82% | 15.82% |
| Shareholder Count | 54 | 55 | 55 | 55 | 54 | 55 | 55 | 55 |
Triochem Products Share Dividend Screener - Share Yield Analysis
Check Triochem Products dividend history with payout and yield data.
View Triochem Products dividend details including ex-dates and amounts for TRIPR stock.
Triochem Products Stock Index Membership
See which indices include Triochem Products stock.
Check TRIPR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Triochem Products Market Events Screener - Corporate Actions
Get Triochem Products corporate actions including splits, bonuses, and buybacks.
Check Triochem Products stock events that may affect TRIPR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-22 | 2026-08-22 | Annual General Meeting | NA | - |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | - |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | - |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | - |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | - |
| 2025-06-25 | 2025-06-25 | Annual General Meeting | NA | - |
| 2025-05-24 | 2025-05-24 | Quarterly Result Announcement | NA | - |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | - |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | - |
| 2024-08-22 | 2024-08-22 | Annual General Meeting | NA | - |
Triochem Products Competitors Screener - Peer Comparison
Screen TRIPR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 446,948 | 39.08 | 58,220 | 6.38% | 11,565 | 62.37 |
| Divis Laboratories | 178,222 | 69.79 | 10,560 | 8.73% | 2,520 | 52.31 |
| Torrent Pharmaceuticals | 152,849 | 71.28 | 13,886 | 20.34% | 2,138 | 56.90 |
| Cipla | 116,329 | 30.07 | 29,045 | 2.24% | 3,870 | 65.46 |
| Dr Reddys Laboratories | 112,719 | 26.67 | 33,593 | -0.44% | 3,998 | 69.37 |
| Zydus Life Science | 110,827 | 21.58 | 26,720 | 13.65% | 5,242 | 61.62 |
| Lupin | 107,108 | 20.22 | 27,488 | 19.98% | 5,345 | 58.20 |
| Mankind Pharma | 101,645 | 52.76 | 14,278 | 12.03% | 1,750 | 57.08 |
| Aurobindo Pharma | 90,326 | 25.36 | 33,385 | 3.21% | 3,376 | 67.06 |
| Laurus Labs | 78,279 | 88.23 | 6,868 | 22.01% | 890 | 64.65 |
Triochem Products Company Announcements - News Screener
Screen TRIPR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-29 | Intimation Of Book Closure/Record Date - Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 | - |
| 2026-05-29 | Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32(1) Of The SEBI (Listing Obligation & Disclosures Requirement) Regulation 2015 For The Quarter Ended 31St March 2026. | - |
| 2026-05-29 | Non-Applicability Of Regulation 23(9) Of SEBI (LODR) (Amendments) Regulation 2018 | - |
| 2026-05-29 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-29 | Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2026 | - |
| 2026-05-29 | Board Meeting Outcome for Outcome Of Board Meeting Held On Friday May 29 2026 | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-22 | Board Meeting Intimation for Intimation Of Board Meeting For The Quarter And Year Ended 31St March 2026 Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-04-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-16 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-04-16 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-16 | Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount For Loans Including Revolving Facilities Like Cash Credit From Banks / Financial Institutions | - |
| 2026-04-16 | Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt Securities | - |
| 2026-04-16 | Compliance-57 (5) : intimation after the end of quarter | - |
| 2026-03-20 | Board Meeting Outcome for Outcome Of The Independent DirectorS Meeting - Pursuant To Regulation 25(3) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulation 2015 | - |
| 2026-03-19 | Closure of Trading Window | - |
| 2026-03-19 | Compliance-57 (4) : Prior intimation to the beginning of the quarter | - |
| 2026-03-13 | Board Meeting Intimation for Intimation Separate Board Meeting Of Independent DirectorS Under Regulation 25(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-02-23 | Re-Submission Of Unaudited Standalone Financial Results For The Quarter And Nine Months Ended 31St December 2025. Refer Your Email Dated 20Th February 2026 | - |